British Columbia Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,300
Closed -$2.6M 835
2022
Q3
$2.6M Hold
19,300
0.03% 398
2022
Q2
$3.12M Sell
19,300
-1,175
-6% -$184K 0.03% 401
2022
Q1
$3.86M Buy
20,475
+1,175
+6% +$250K 0.02% 453
2021
Q4
$5.23M Buy
19,300
+100
+0.5% +$33.8K 0.03% 434
2021
Q3
$6.97M Hold
19,200
0.04% 354
2021
Q2
$6.59M Sell
19,200
-200
-1% -$66.2K 0.04% 371
2021
Q1
$6.75M Hold
19,400
0.05% 310
2020
Q4
$5.01M Buy
19,400
+17,900
+1,193% +$4.93M 0.04% 382
2020
Q3
$430K Sell
1,500
-100
-6% -$23.5K ﹤0.01% 801
2020
Q2
$301K Sell
1,600
-800
-33% -$130K ﹤0.01% 795
2020
Q1
$295K Sell
2,400
-1,500
-38% -$235K 0.01% 789
2019
Q4
$646K Sell
3,900
-16,438
-81% -$2.73M ﹤0.01% 808
2019
Q3
$2.49M Buy
20,338
+11,000
+118% +$1.46M 0.02% 513
2019
Q2
$1.16M Sell
9,338
-1,600
-15% -$203K 0.01% 749
2019
Q1
$1.44M Buy
10,938
+5,838
+114% +$788K 0.01% 709
2018
Q4
$715K Buy
+5,100
New +$676K 0.01% 746

Other funds holding ONC

British Columbia Investment Management's ONC Position: Q4 2022 in Review

British Columbia Investment Management sold out of BeOne Medicines Ltd (ONC) in Q4 2022, closing a stake of 19,300 shares — an estimated $2.6M sold.

British Columbia Investment Management first reported a position in ONC in Q4 2018 and held it in 16 quarters. The position peaked at $6.97M in Q3 2021. 214 funds tracked by Wall St. Rank hold ONC as of Q4 2022.

  • British Columbia Investment Management reported no remaining BeOne Medicines Ltd position as of Q4 2022 after selling out during the quarter.
  • British Columbia Investment Management sold 19,300 BeOne Medicines Ltd shares in Q4 2022, an estimated $2.6M.
  • British Columbia Investment Management first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 16 quarters.
  • British Columbia Investment Management's BeOne Medicines Ltd position peaked at $6.97M in Q3 2021.
  • 214 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2022.

Based on British Columbia Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.